Valor Compounding Pharmacy Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Valor Compounding Pharmacy's estimated annual revenue is currently $8.2M per year.(i)
  • Valor Compounding Pharmacy's estimated revenue per employee is $201,000

Employee Data

  • Valor Compounding Pharmacy has 41 Employees.(i)
  • Valor Compounding Pharmacy grew their employee count by -2% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.4M2-67%N/AN/A
#2
$32M1593%N/AN/A
#3
$35M1213%$62.5MN/A
#4
$30.2M15018%N/AN/A
#5
$135.9M676-1%N/AN/A
#6
$14.9M972%$173MN/A
#7
$110.3M549N/AN/AN/A
#8
$62.7M312-3%N/AN/A
#9
$4.9M4932%N/AN/A
#10
$9.2M46-2%N/AN/A
Add Company

Valor is a specialized compounding pharmacy that customizes medications to fit the unique needs of each individual patient. Our mission is to reinvent compounding pharmacy. We work with a network of providers, patients, health systems, institutions, and research scientists throughout the United States. We believe that the most dangerous phrase in our industry is “it’s always been done that way”. We seek to change how you think about and view compounding pharmacy. We are your proactive partner in health care. We are nimble and responsive. The average turnaround time for a compounding pharmacy is 7 days. We do it in 2 to 4! We are data driven: we monitor key metrics, use, and analyze data to improve our operations to produce the highest quality service and product for our patients and customers. We reduce patient anxiety – and who doesn’t need less anxiety in today’s world? How? By communicating with our patients every step of the way until the prescription is filled and in your hand or delivered free to your door.

keywords:N/A

N/A

Total Funding

41

Number of Employees

$8.2M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.8M4121%N/A
#2
$7.5M4114%N/A
#3
$5.9M41-2%N/A
#4
$8.9M4111%N/A
#5
$8.9M41-15%N/A